‘Tesla Model Y overtakes Volkswagen Golf to become Europe’s best-selling car in November’ -Teslarati
https://twitter.com/Teslarati/status/1608441594323271683
Freight Technologies Says Now Supports Cross-Border Logistics Requirements For An Electric-Electronic Company
HOUSTON, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (NASDAQ:FRGT) ("Fr8Tech''), a technology company whose custom-developed Fr8App platform is powered by AI and machine-learning and offers
Laser Photonics Highlights Demonstration Of CleanTech Laser Systems For Anniston Army Depot Soldiers
ORLANDO, FL / ACCESSWIRE / December 29, 2022 / Laser Photonics Corporation (NASDAQ:LASE), ("LPC"), a leading global developer of Cleantech laser systems for laser cleaning and other materials applications,
CytoSorbents Receives $5M In Non-Dilutive Debt Financing From Bridge Bank And Extends Loan Agreement
PRINCETON, N.J., Dec. 29, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery
Pfizer Announces Top-Line Results From Phase 3 Study Of Hemophilia B Gene Therapy Candidate; Study Met Primary Endpoint
The BENEGENE-2 study met its primary endpoint of non-inferiority and superiority in the annualized bleeding rate (ABR) of total bleeds post-fidanacogene elaparvovec infusion versus prophylaxis regimen with Factor IX
Check Point Software Harmony Endpoint Integrates Intel vPro Platform
SAN CARLOS, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Check Point® Software Technologies Ltd. (NASDAQ:CHKP), a leading provider of cyber security solutions globally, today announced an extended
Graphex Technologies Enters into MOU with Reforme Group Pty Ltd To Develop Graphite Manufacturing Facilities In Australia For Mine-To-Battery Graphite Supply To The EV Industry
The strategic collaboration will pursue upstream and downstream opportunities to supply critical graphite anode materials to the global EV industry through streamlined, localized supply chains
Graphex Technologies, LLC,
Can-Fite BioPharma To Present Liver Cancer Data At Upcoming Conferences
Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today provided an update on